Which patents cover Myleran, and what substitute generic drugs are available?Myleran is a drug marketed by Aspen Global and is included in one NDA.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|TABLET;ORAL||009386-001||Approved Prior to Jan 1, 1982||RX||Yes||Yes||► Subscribe||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.